Top Markets
Coin of the day
Hunan Er-Kang Pharmaceutical Co., Ltd Hunan Er-Kang Pharmaceutical Co., Ltd

Hunan Er-Kang Pharmaceutical Co., Ltd

300267
株式のランク #9472
Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that... Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.
株価
$0.48835979
最終同期: 2026-08-28
時価総額
$1.01B
変化(1日)
-1.46%
変化(1年)
-9.78%
CN
取引 Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

カテゴリー

Hunan Er-Kang Pharmaceutical Co., Ltd(300267)の利益
2026 時点の利益 TTM: 0
Hunan Er-Kang Pharmaceutical Co., Ltd の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Hunan Er-Kang Pharmaceutical Co., Ltd の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。